Skip to content
Medical Health Aged Care, Women

Investing in nurses to lead community education and care for people experiencing menopause and perimenopause

Australian College of Nursing 2 mins read

In its 2025-26 Pre-Budget Submission, the Australian College of Nursing (ACN) is calling on the Federal Government to fund measures to support nurses experiencing perimenopause and menopause.

With women comprising 88 per cent of Australia's nursing workforce and approximately half of these nurses at an age where they may experience perimenopause or menopause, ACN is advocating for targeted initiatives to address this critical but often overlooked health issue.

ACN CEO, Adjunct Professor Kathryn Zeitz FACN, said that investing in the health of nurses experiencing menopause will empower these nurses to provide informed education and care in the broader Australian community.

“The nursing profession is predominantly female, with more than 344,000 women serving as the backbone of our healthcare system,” Adjunct Professor Zeitz said.

“Yet many of these dedicated professionals face significant challenges personally as they navigate perimenopause and menopause, often without adequate workplace support or understanding.”

Research shows that around 80 per cent of women experience symptoms associated with menopause, including hot flushes, insomnia, mood changes, and cognitive challenges. These symptoms can significantly impact physical health, mental wellbeing, and the ability to perform in demanding roles like nursing.

ACN is calling for an $8 million investment to implement two key recommendations:

  1. $5 million for a national awareness campaign about the impacts of perimenopause and menopause in the nursing workforce,
  2. $3 million to develop and deliver an online perimenopause and menopause education program for nurses, incorporating a train-the-trainer approach.

“This investment is not just about supporting individual nurses – it's about strengthening our entire healthcare system,” Professor Zeitz said.

“By equipping nurses with the knowledge and resources to navigate these life stages, we can improve workforce retention, enhance career longevity, and ultimately deliver better health outcomes for all Australians.”

The national campaign would focus on improving visibility, reducing stigma, and encouraging open dialogue about menopause-related symptoms in the workplace. It would also promote symptom management strategies, psychological support, and occupational health initiatives to create a supportive environment for affected nurses.

The education program would equip nurses with the knowledge and skills to identify, manage, and support women experiencing menopause, both among their colleagues and patients. A train-the-trainer model could amplify the program's impact by enabling nurses to share knowledge widely within their communities.

“With nurses being the most geographically dispersed health professionals, providing care across the lifespan and in diverse settings, these initiatives will strengthen their ability to deliver high-quality, person-centred care, benefiting women and communities in its broadest sense,” Professor Zeitz said.

ACN's Pre-Budget Submission outlines a comprehensive framework for governments to invest in and support nurses, nursing, and the health system, empowering nurses to provide culturally safe, patient-centred care across multiple settings.

ACN notes that most people who experience menopause are genetically female and identify as women, but that transgender people, and many gender identities also experience menopause.

The Federal Government has already made addressing menopause and perimenopause in the community a priority, including announcing in February:

  • More Medicare support for women experiencing menopause, with a new Medicare rebate for menopause health assessments, funding to train health professionals, the first-ever clinical guidelines, and a national awareness campaign;
  • The first PBS listing for new menopausal hormone therapies in over 20 years, with around 150,000 women saving hundreds of dollars a year from the listing of Prometrium®, Estrogel® and Estrogel® Pro.

Contact details:

Lexi Metherell 0449 803 524

Email: [email protected]

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.